The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Rifaximin versus chlortetracycline in the short‐term treatment of small intestinal bacterial overgrowth2000 · 155 citations
2. 2Irregular gastrointestinal drug absorption in Parkinson's disease2008 · 116 citations
3. 3The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic2014 · 9,597 citations
4. 4First encounters of the microbial kind: perinatal factors direct infant gut microbiome establishment2022 · 24 citations
5. 5Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease2024 · 23 citations